TNNT2 and coronary artery disorder: The median hs-cTnT concentrations in type 2 NSTEMI patients with and without CAD were 300 (119–773) ng/L and 244 (107–587) ng/L (p < 0.001), and 308 (123–794) ng/L and 228 (102–543) ng/L in type 2 NSTEMI patients with and without CVD (p < 0.001).